Regulatory Operations
QRD Preparation and Guidelines for EMA Compliance
Ensuring Compliance with EMA's Quality Review of Documents (QRD) Guidelines
Ensuring Compliance with EMA's Quality Review of Documents (QRD) Guidelines
The Quality Review of Documents (QRD) is an essential step in the regulatory approval process for pharmaceutical products within the European Union (EU). The QRD ensures that all the product information submitted for medicinal products complies with the EU Directive 2001/83/EC and other relevant regulations. Techsol Life Sciences specializes in QRD preparation, ensuring that the Summary of Product Characteristics (SmPC), Patient Information Leaflet (PIL), and Labeling are accurate, regulatory-compliant, and aligned with EMA guidelines.
QRD Preparation Process for EMA
Techsol Life Sciences follows a structured approach to QRD preparation, which involves detailed compliance with EMA guidelines and standards. Our process ensures that all documents adhere to the European Medicines Agency (EMA) regulatory requirements.
Key Documents and Templates Used in QRD Preparation
The QRD Annotated Template provides a framework for preparing the SmPC, PIL, and labeling documents. It offers guidance on the required content for each section and how to format and structure these documents. This template is essential for ensuring consistency and alignment with EMA guidelines.
This EU Directive lays down the legal foundation for the marketing authorization of medicinal products for human use, covering essential aspects of the product’s information and labeling. The directive is key to understanding regulatory obligations and the general requirements for the SmPC, PIL, and other documentation.
This template is specifically designed for the preparation of product information documents and includes detailed instructions for formatting, content, and submission of the SmPC, PIL, and labeling. It is a crucial document in ensuring the standardization of medicinal product information across the EU.
The Compilation of Quality Review Documents (QRD) guideline addresses the stylistic aspects of the product information, ensuring that the formatting, language, and tone are consistent and aligned with EU regulations. This guideline helps ensure that the product information is clear, concise, and accessible to healthcare professionals and patients.
The SmPC is a comprehensive document that provides detailed information about the medicinal product, including its therapeutic indications, contraindications, dosage, and administration. It is used primarily by healthcare professionals to make informed decisions about prescribing the product. The QRD template guides the content and structure of the SmPC, ensuring regulatory compliance.
These templates help ensure that all documents submitted for regulatory approval comply with the EMA’s formatting and content requirements. They ensure clarity and precision in conveying product information to the regulatory authorities.

Techsol Life Sciences Approach to QRD Preparation
Techsol’s approach to QRD preparation involves meticulous attention to detail and alignment with EMA regulations. Here is an overview of how we manage the QRD process:
- Document Review and Gap Analysis: We begin by reviewing your existing product information documents (SmPC, PIL, Labeling) and performing a gap analysis to identify any missing or non-compliant content. This analysis ensures that your documents meet EMA’s high standards and regulations.
- Template-Based Document Drafting: Using the latest QRD annotated templates, we help draft or update your SmPC, PIL, and labeling in line with EMA guidelines. This template-based approach ensures consistency and compliance with EU regulatory requirements.
- Stylistic and Formatting Compliance: We ensure that your documents comply with the QRD stylistic guidelines, including the appropriate use of headings, bullet points, and terminology. This guarantees that the content is not only accurate but also easily understood by healthcare professionals and patients.
- Quality Review and Finalization: Once all documents are drafted, we conduct a thorough quality review to check for accuracy, consistency, and regulatory compliance. This final check ensures that all necessary information is included, and the formatting is aligned with the QRD guidelines.
- Submission Support: After the preparation of SmPC, PIL, and labeling documents, we provide full submission support to EMA or other regional authorities, ensuring that your product information complies with all required guidelines and is ready for approval.


Key Benefits of QRD Preparation Services by Techsol
Our approach combines in-depth regulatory knowledge, template-driven efficiency, and expert quality checks to deliver accurate and compliant SmPC, PIL, and labeling documents for pharmaceutical products.
- Regulatory Compliance: Techsol ensures your SmPC, PIL, and labeling documents are meticulously prepared in full alignment with EMA’s QRD guidelines, reducing the risk of regulatory delays or refusals.
- Streamlined Submission Process: Our template-driven, process-oriented approach enables the efficient preparation of product information documents, ensuring that every submission is clear, complete, and regulator-ready.
- Timeliness and Accuracy: Leveraging our extensive regulatory experience, Techsol delivers accurate and up-to-date documentation fully compliant with current EU and national regulations, helping sponsors save time and avoid costly rework.
- Global Expertise: Techsol supports multi-regional submissions to EMA and other global regulatory authorities, ensuring consistent and compliant medicinal product information across international markets.
Regulatory Operations Services
Latest Relevant Case Studies

May 1, 2025
Specialized Regulatory Writing Solutions for Clinical Overviews in Combination Therapy Submissions

April 29, 2025
Developing a complex clinical trial Protocol for a CNS-based Psychiatric product …

June 10, 2025
Case study on regulatory strategy development and dossier submission support
Latest Relevant Insights

July 12, 2023
Mastering Medical Device Registrations: A Guide to Navigating Regulatory Pathways

June 21, 2021
Evolution in Global Pharmaceutical Regulatory Landscape & Notable Changes for Sponsors

June 5, 2021
Emerging Trends in Regulatory Affairs by Adapting to Latest Technological Advancements